Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection
Autor: | Chen Hsuan Hsu, Jung Chen Lin, Hui-Wen Chen, Yuan-I Chen, Chen Yu Huang, Che Ming Jack Hu, Zih Syun Fang, Shu-Yi Lin, Bing Yu Yao |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Infectious bronchitis virus Antigen presentation Biophysics Nanoparticle tracking analysis Bioengineering Protein Corona 02 engineering and technology Biology Protein Engineering medicine.disease_cause Article Virus Microbiology Birds Biomaterials 03 medical and health sciences Immune system Antigen medicine Gold nanoparticles Animals Vaccines Virus-Like Particle Spike proteins Coronavirus Virus-like particles 021001 nanoscience & nanotechnology Virology Vaccination Treatment Outcome 030104 developmental biology Protein corona Mechanics of Materials Spike Glycoprotein Coronavirus Ceramics and Composites Nanoparticles Gold Coronavirus Infections 0210 nano-technology |
Zdroj: | Biomaterials |
ISSN: | 0142-9612 |
DOI: | 10.1016/j.biomaterials.2016.08.018 |
Popis: | The ongoing battle against current and rising viral infectious threats has prompted increasing effort in the development of vaccine technology. A major thrust in vaccine research focuses on developing formulations with virus-like features towards enhancing antigen presentation and immune processing. Herein, a facile approach to formulate synthetic virus-like particles (sVLPs) is demonstrated by exploiting the phenomenon of protein corona formation induced by the high-energy surfaces of synthetic nanoparticles. Using an avian coronavirus spike protein as a model antigen, sVLPs were prepared by incubating 100 nm gold nanoparticles in a solution containing an optimized concentration of viral proteins. Following removal of free proteins, antigen-laden particles were recovered and showed morphological semblance to natural viral particles under nanoparticle tracking analysis and transmission electron microscopy. As compared to inoculation with free proteins, vaccination with the sVLPs showed enhanced lymphatic antigen delivery, stronger antibody titers, increased splenic T-cell response, and reduced infection-associated symptoms in an avian model of coronavirus infection. Comparison to a commercial whole inactivated virus vaccine also showed evidence of superior antiviral protection by the sVLPs. The study demonstrates a simple yet robust method in bridging viral antigens with synthetic nanoparticles for improved vaccine application; it has practical implications in the management of human viral infections as well as in animal agriculture. Graphical abstract |
Databáze: | OpenAIRE |
Externí odkaz: |